For people whose depression has not improved enough with conventional treatment, exploring additional treatment options may be an important next step. SpravatoÂŽ (esketamine) nasal spray is an FDA-approved treatment used for specific depressive conditions, including treatment-resistant depression in adults. However, Spravato is not appropriate for everyone, and patients need a professional evaluation before treatment can begin.
Understanding how to get evaluated for Spravato therapy can help patients prepare for their psychiatric consultation, understand what providers look for, and make informed decisions about their depression treatment options.
What is Spravato Therapy?
Spravato is the brand name for esketamine nasal spray, a prescription treatment used for specific depressive conditions, including treatment-resistant depression. The FDA has approved Spravato for adults with treatment-resistant depression and for depressive symptoms in adults with major depressive disorder accompanied by acute suicidal ideation or behavior, when used according to its approved prescribing requirements.
Spravato is administered in a certified healthcare setting rather than being taken independently at home. Because treatment can cause effects such as sedation, dissociation, and increases in blood pressure, patients require monitoring following administration, as detailed in the FDA-approved Spravato prescribing information. The treatment is subject to the Spravato REMS (Risk Evaluation and Mitigation Strategy) program.
For this reason, a Spravato therapy evaluation is an important first step in determining whether esketamine treatment may be suitable.
Knowing how to get evaluated for Spravato therapy can help patients understand whether they may be considered for this treatment.
Who May Be Considered for Spravato Therapy?
Spravato may be considered for adults with treatment-resistant depression, particularly when previous antidepressant treatment has not provided adequate improvement.
Understanding how to get evaluated for Spravato therapy is especially important for people who have experienced limited improvement from previous depression treatments.
Treatment-resistant depression generally refers to depression that continues despite appropriate treatment attempts. During a psychiatric evaluation, the provider does not simply look at how many medications a patient has tried. The clinician considers the type of medication, dosage, treatment duration, adherence, response, side effects, and other relevant factors.
A psychiatric evaluation for Spravato may also consider the patient’s current symptoms, diagnosis, medical history, other psychiatric conditions, medications, and overall safety.
Not every person with depression is automatically a candidate for esketamine treatment. A qualified healthcare professional must determine whether the treatment is appropriate based on the patient’s individual circumstances.
How to Get Evaluated for Spravato Therapy
The steps involved in getting evaluated for Spravato therapy help providers determine whether the treatment is clinically appropriate and safe.
1. Schedule a Psychiatric Evaluation
The first step is to schedule an appointment with a qualified psychiatric provider. The initial consultation allows the clinician to understand the patient’s mental health concerns and review previous treatment.
Patients who want to know how to get evaluated for Spravato therapy should be prepared to discuss their current symptoms and previous mental health treatment.
At Options Psychiatry in Reading, PA, the initial psychiatric evaluation focuses on understanding the patient’s needs, medical and psychiatric history, symptoms, and treatment goals. The practice provides individualized psychiatric care, medication management, counseling, and other mental health treatment options.
During an evaluation, patients can also discuss whether Spravato for treatment-resistant depression or another evidence-based treatment may be appropriate.
2. Review Your Depression Symptoms
A provider will first evaluate the patient’s current depressive symptoms and their impact on daily functioning.
The assessment may include symptoms such as:
- Persistent sadness or low mood
- Loss of interest or pleasure
- Low energy and fatigue
- Difficulty concentrating
- Changes in sleep
- Changes in appetite
- Feelings of hopelessness
- Feelings of guilt or worthlessness
- Reduced motivation
- Difficulty functioning at work or home
- Suicidal thoughts or other safety concerns
These details are an important part of how to get evaluated for Spravato therapy because they help the provider understand the severity and impact of depression.
Understanding the severity, duration, and pattern of depressive symptoms helps the clinician establish an accurate diagnosis and determine an appropriate treatment approach.
3. Discuss Your Previous Antidepressant Treatment
A detailed treatment history is one of the most important parts of a Spravato eligibility evaluation because treatment-resistant depression is assessed based on a patient’s response to previous treatments.
Patients should tell their provider about previous medications and treatments, including:
- Names of antidepressants taken
- Dosages, if known
- How long each medication was used
- Whether symptoms improved
- How much improvement occurred
- Whether symptoms returned
- Side effects experienced
- Reasons for stopping a medication
- Other depression treatments attempted
Patients who have records from previous psychiatrists or primary care providers may want to bring them to the appointment.
This information helps the clinician determine whether the patient’s depression may meet the clinical definition of treatment resistance.
4. Review Your Current Medications
A provider will review all medications the patient is currently taking. This may include antidepressants, mood stabilizers, antipsychotic medications, anxiety medications, sleep medications, blood-pressure medications, supplements, and other prescriptions.
The FDA states that esketamine is used with an oral antidepressant for its approved indications. Medication interactions and the patient’s overall treatment plan should therefore be reviewed carefully before treatment begins.
Patients should provide an accurate and complete medication list during their Spravato consultation.
5. Review Your Medical and Psychiatric History
A comprehensive esketamine treatment evaluation involves more than reviewing depression symptoms.
The healthcare provider may discuss:
- Previous psychiatric diagnoses
- History of mania or hypomania
- Anxiety symptoms
- Trauma-related symptoms
- Substance use
- Previous psychiatric hospitalization
- Medical conditions
- Cardiovascular history
- Previous medication reactions
- Pregnancy or plans for pregnancy, when clinically relevant
- Current or previous suicidal thoughts or behaviors
This medical and psychiatric information is another important part of how to get evaluated for Spravato therapy.
This information allows the provider to evaluate potential risks and determine whether Spravato is appropriate.
6. Discuss Treatment Resistance
One of the central considerations in evaluating Spravato for depression is whether a patient has experienced inadequate improvement from previous antidepressant treatment.
Treatment resistance can involve several factors. A patient may have taken an appropriate antidepressant but experienced little improvement, partial improvement, or a return of symptoms after an initial response.
For patients learning how to get evaluated for Spravato therapy, documenting previous treatment attempts can help the provider assess treatment resistance.
The psychiatrist will evaluate the patient’s treatment history rather than relying solely on the patient’s description of having “tried everything.”
Accurate documentation can be particularly helpful when insurance authorization or medical-necessity requirements apply.
7. Evaluate Safety and Potential Risks
Spravato has important safety considerations. The FDA prescribing information includes warnings related to sedation, dissociation, respiratory depression, increased blood pressure, abuse and misuse, and impaired ability to drive or operate machinery.
Because of these risks, Spravato must be administered in a certified healthcare setting under appropriate supervision. Patients are monitored after receiving a dose rather than immediately leaving the treatment facility.
The provider will consider the patient’s medical history and individual risk factors before recommending treatment.
8. Determine Whether Spravato Is Appropriate
After reviewing the patient’s diagnosis, symptoms, treatment history, medications, medical conditions, and safety considerations, the clinician can determine whether Spravato therapy is an appropriate option.
The outcome of an evaluation can vary. A patient may be considered an appropriate candidate, may need additional records or evaluation, or may be advised to consider another treatment.
This individualized process is important because there is no single treatment that works for every person with depression.
What Should You Bring to a Spravato Evaluation?
Preparing before your psychiatric consultation can make it easier for your provider to understand your treatment history.
Consider bringing:
- A current medication list
- Names of previous antidepressants
- Previous medication doses, if available
- Approximate treatment dates
- Information about medication side effects
- Previous psychiatric records
- Relevant medical records
- Information about previous depression treatments
- Insurance information
- A list of questions about esketamine treatment
If you do not remember every medication you have taken, do not worry. Your provider can help determine what additional information or records may be needed.
What Happens After a Spravato Evaluation?
If the provider determines that Spravato may be appropriate, the next steps involve developing a treatment plan and completing any necessary clinical and administrative requirements.
Spravato must be administered under healthcare-provider supervision through the required REMS program. Patients are monitored following administration because of potential sedation, dissociation, and other risks.
The treatment plan may also include continuing an oral antidepressant and monitoring the patient’s response over time, depending on the approved indication and individual clinical circumstances.
Does Insurance Cover Spravato?
Insurance coverage for Spravato can vary significantly between health plans, and understanding Spravato insurance coverage can help patients prepare for potential authorization and out-of-pocket costs. Coverage may depend on the patient’s diagnosis, previous treatment history, medical necessity, authorization requirements, and individual insurance policy.
Before starting treatment, patients should ask about:
- Insurance eligibility
- Prior authorization
- Medical-necessity requirements
- Required treatment documentation
- Copayments or coinsurance
- Deductibles
- Out-of-pocket costs
Options Psychiatry states that its team works with patients regarding insurance and provides information about accepted insurance plans and coverage. Patients should confirm current coverage and Spravato-specific benefits directly with the practice and their insurer.
Spravato Evaluation vs. Other Depression Treatment Options
A Spravato assessment does not necessarily mean that Spravato will be the recommended treatment, and learning about TMS therapy vs. Spravato can help patients understand how these treatment approaches differ.
Depending on the diagnosis and treatment history, a psychiatrist may discuss options including medication management, psychotherapy, or other advanced depression treatments.
For example, TMS is a non-invasive treatment that uses magnetic pulses to stimulate specific areas of the brain, and understanding who is eligible for TMS therapy can help patients explore whether it may be an appropriate alternative.
The right treatment depends on the patient’s diagnosis, previous treatment response, medical history, preferences, and clinical needs.
Why a Professional Spravato Evaluation Matters
A professional Spravato evaluation allows the psychiatrist to make treatment decisions based on a patient’s complete clinical picture.
Depression can have different causes, symptoms, and treatment responses, which is why understanding how depression treatment works can help patients make informed decisions about their care. A thorough evaluation gives the psychiatrist an opportunity to determine whether the patient has treatment-resistant depression, review previous antidepressant treatment, identify potential safety concerns, and discuss appropriate treatment options.
For patients in Reading, PA, Options Psychiatry provides psychiatric evaluations, medication management, counseling, and individualized mental health care. Its clinical approach emphasizes understanding each patient’s needs before developing a treatment plan.
Conclusion
Knowing how to get evaluated for Spravato therapy can make the process easier for people who are experiencing depression that has not responded adequately to previous treatments. The process begins with a comprehensive psychiatric evaluation rather than simply requesting the medication.
During the evaluation, a provider reviews the patient’s depression symptoms, diagnosis, previous antidepressant treatment, current medications, medical history, treatment response, and potential safety considerations. This assessment helps determine whether Spravato for treatment-resistant depression may be appropriate or whether another approach may better fit the patient’s needs.
For individuals seeking psychiatric care in Reading, PA, working with an experienced psychiatric provider can provide clarity about available depression treatment options. Options Psychiatry offers personalized psychiatric evaluations and medication management in Reading, PA, helping patients understand their treatment choices and develop an individualized plan for mental health care.
Frequently Asked Questions
1. How do I get evaluated for Spravato therapy?
You typically begin by scheduling a psychiatric evaluation with a qualified mental health provider. The provider reviews your depression symptoms, diagnosis, previous treatments, medications, medical history, and treatment response to determine whether Spravato may be appropriate.
2. Who may qualify for Spravato therapy?
Spravato may be considered for adults with treatment-resistant depression. Your provider will determine eligibility based on your individual clinical history.
3. What happens during a Spravato evaluation?
The provider reviews your symptoms, previous antidepressant treatments, current medications, medical history, and treatment response before recommending treatment.
4. Does insurance cover Spravato?
Coverage varies by insurance plan. Some plans may require prior authorization and documentation of previous depression treatments.
5. What if Spravato is not right for me?
Your provider can discuss other depression treatment options, such as medication management, psychotherapy, or TMS therapy, based on your needs.
6. Is Spravato administered at home?
No. Spravato must be administered under healthcare provider supervision in a certified healthcare setting, with monitoring after treatment.